Zhengye Biotechnology Holding Ltd
Research Zhengye Biotechnology Holding Ltd (ZYBT) on Bullrun: market cap USD 81.99M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerZYBT
- ExchangeNASDAQ
- CountryChina
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 81.99M
- Financial periodFY2025
- RevenueCNY 116.36M
- Revenue growth-37.6%
- Net income-CNY 69.78M
- Free cash flowCNY 703.00K
- Gross margin20.5%
Valuation Snapshot
latest market cap is USD 81.99M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 116.36M | -CNY 69.78M | CNY 703.00K | 20.5% | n/a | CNY 50.33M | CNY 75.08M | CNY 249.85M |
| FY2024 | CNY 186.36M | CNY 11.31M | CNY 13.27M | 49.0% | 0.24 | CNY 18.60M | CNY 86.43M | CNY 283.96M |
| FY2023 | CNY 211.65M | CNY 31.46M | CNY 36.58M | 55.5% | 0.67 | CNY 15.07M | CNY 89.85M | CNY 272.85M |
| FY2022 | CNY 260.27M | CNY 46.74M | -CNY 9.99M | 56.8% | 0.99 | CNY 9.75M | CNY 64.88M | CNY 296.50M |
| FY2021 | CNY 214.07M | CNY 38.96M | CNY 5.41M | 58.6% | 0.83 | CNY 6.28M | CNY 30.00M | CNY 267.47M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 81.99M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 54.50M | n/a | n/a | n/a |
About Zhengye Biotechnology Holding Ltd
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Zhengye Biotechnology Holding Ltd's market cap?
Zhengye Biotechnology Holding Ltd's market capitalization is USD 81.99M.
What does Zhengye Biotechnology Holding Ltd do?
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs. In addition, the company exports its products to Vietnam, Pakistan, and Egypt.